https://www.selleckchem.com/products/azd2014.html
Diazepam-binding inhibitor (DBI) controls feeding behaviour and glucose homeostasis. Individuals born small-for-gestational-age (SGA) with excessive postnatal catch-up in weight are at risk for obesity and type 2 diabetes. To assess serum concentrations of DBI (0-2 years) in appropriate-for-gestational-age (AGA, n= 7 vs SGA infants (n= 33) with spontaneous catch-up and their relationship with endocrine-metabolic and adiposity markers. Longitudinal assessments included auxology, fasting glucose, insulin, insulin-like growth factor, hig
Gefällt mir
Kommentar
Teilen
